Mindfulness program to improve nutrition for breast cancer survivors
Mindfulness Intervention for Nutrition in the Digital Kitchen (MIND) Study: A Pilot and Feasibility Study
NA · Fred Hutchinson Cancer Center · NCT06643455
This study is testing if a 6-week online program that teaches cooking and healthy eating can help breast cancer survivors improve their diets.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fred Hutchinson Cancer Center (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT06643455 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of a remote nutrition and culinary intervention aimed at enhancing diet quality among survivors of stage I-III breast cancer. Participants are randomly assigned to either an intervention group, which engages in a 6-week online program focusing on nutrition education, cooking skills, and mindfulness practices, or a waitlist control group receiving standard care. The intervention is delivered through the Cook for Your Life platform, which provides interactive resources and evidence-based information on nutrition for cancer survivors. Follow-up assessments are conducted 12 weeks after the intervention to measure outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with stage I-III breast cancer within the last 5 years and are at least 60 days post-treatment.
Not a fit: Patients with current, recurrent, or metastatic breast cancer may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this program could significantly improve the dietary habits and overall health of breast cancer survivors.
How similar studies have performed: Previous studies have shown promise in using technology-based interventions for dietary improvements in cancer survivors, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older. * Previous diagnosis of stage I-III breast cancer in the past 5 years at the time of enrollment. * No evidence of current, recurrent or metastatic disease. * At least 60 days post final chemotherapy, biologic therapy, or radiation therapy and/or surgery. The following which are allowed: HER2-targeted therapies, CDK4/6 inhibitor (abemaciclib or ribociclib), endocrine therapy (aromatase inhibitors, ovarian suppression therapy, and tamoxifen), PARP inhibitors (olaparib), and zolendronic acid. * Access to phone for study contacts. * Access to smartphone, tablet, or computer and internet to attend online program. * Willing and able to complete all study activities after randomization, including completing surveys online, at-home, and over the telephone assessments. * Able to understand and willing to sign written informed electronic (e) consent in English * Eastern Cooperative Oncology Group (ECOG) status of 0-2. * Participants must not be actively smoking within the past 30 days. Active smoking is defined as any smoking, even a puff. Participants who smoke are much less likely to engage in healthy lifestyle behaviors, and it is probably more important for participants to stop smoking than it is to change their dietary patterns. If identified as actively smoking, the individual will be referred to the local resources, Washington State Quitline (1-800-QUIT-NOW), ICanQuit.org, Quit2Heal.org, the national resource, Centers for Disease Control and Prevention (CDC) "Quit Now" phone line which supports smoking cessation, or the NIH quit support website "SmokeFree.gov. * Participants must consume \< 5 servings of fruits and vegetables per day as assessed by a brief questionnaire. * Physician approval to participate in the MIND program dietary intervention. * At the time of enrollment, women must not be pregnant or lactating or planning to become pregnant in the next 6 months.
Where this trial is running
Seattle, Washington
- Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States (RECRUITING)
Study contacts
- Principal investigator: Heather Greenlee — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Jenny Whitten-Brannon
- Email: jwhitten@fredhutch.org
- Phone: 206.667.5625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8